Application of 201150-73-4, Chemistry is the experimental science by definition. We want to make observations to prove hypothesis. For this purpose, we perform experiments in the lab. 201150-73-4, Name is tert-Butyl 5-amino-3,4-dihydroisoquinoline-2(1H)-carboxylate,introducing its new discovery.
A taxol and […] BTK inhibitor combination pharmaceutical composition and its application (by machine translation)
The invention provides a fluorine taitai qin ketone BTK inhibitor paclitaxel and joint for pharmaceutical composition, characterized in that comprising an active ingredient and a pharmaceutically acceptable auxiliary material, wherein the active ingredient by the taxol of formula (I) of a BTK inhibitors shown, the active ingredient of taxol in the formula (I) indicated by the molar ratio of BTK inhibitors (0.14 – 0.20): 1. The pharmaceutical composition can be used for preparing the prevention and/or treating the Bruton tyrosine kinase-related disease drug, the treatment effect is good. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 201150-73-4, and how the biochemistry of the body works.Application of 201150-73-4
Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem